Search Results

There are 822 results for: content related to: Biologic therapies for psoriasis: practical experience in a U.K. tertiary referral centre

  1. An Overview of the Pharmacokinetics and Pharmacodynamics of Efalizumab: A Monoclonal Antibody Approved for Use in Psoriasis

    The Journal of Clinical Pharmacology

    Volume 46, Issue 1, January 2006, Pages: 10–20, Dr Amita Joshi, Dr Robert Bauer, Dr Peter Kuebler, Mr Mark White, Ms Cecelia Leddy, Mr Peter Compton, Dr Marvin Garovoy, Dr Paul Kwon, Dr Patricia Walicke and Dr Russell Dedrick

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270005283282

  2. Transitioning patients from efalizumab to alternative psoriasis therapies: findings from an open-label, multicenter, Phase IIIb study

    International Journal of Dermatology

    Volume 46, Issue 6, June 2007, Pages: 637–648, Alan Menter, Tiffani K. Hamilton, Darryl P. Toth, Hoi M. Leung, Graham Wetherill, Brian Hennessey, Marvin Garovoy, Paul Kwon, David M. Pariser and (for the Efalizumab Study Group)

    Version of Record online : 5 JUN 2007, DOI: 10.1111/j.1365-4632.2007.03158.x

  3. Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: A phase IIIb, randomized, controlled trial

    International Journal of Dermatology

    Volume 45, Issue 5, May 2006, Pages: 605–614, Kim A. Papp, Reni Bressinck, Scott Fretzin, Bernard Goffe, Steven Kempers, Kenneth B. Gordon, Ivor Caro, Patricia A. Walicke, Xiaolin Wang, Alan Menter and the Efalizumab Study Group

    Version of Record online : 7 FEB 2006, DOI: 10.1111/j.1365-4632.2006.02777.x

  4. Pharmacokinetics and Pharmacodynamics of Multiple Weekly Subcutaneous Efalizumab Doses in Patients With Plaque Psoriasis

    The Journal of Clinical Pharmacology

    Volume 45, Issue 3, March 2005, Pages: 286–298, Ms Deborah L. Mortensen, Dr Patricia A. Walicke, Dr Xiaolin Wang, Dr Paul Kwon, Dr Peter Kuebler, Dr Alice B. Gottlieb, Dr James G. Krueger, Dr Craig Leonardi, Dr Bruce Miller and Dr Amita Joshi

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270004270260

  5. Managing moderate-to-severe psoriasis with efalizumab: experience at a single Spanish institute

    British Journal of Dermatology

    Volume 156, Issue s2, April 2007, Pages: 24–29, C. Ferrándiz and J.M. Carrascosa

    Version of Record online : 16 MAR 2007, DOI: 10.1111/j.1365-2133.2007.07766.x

  6. Long-term treatment of plaque psoriasis with efalizumab: an Italian experience

    British Journal of Dermatology

    Volume 156, Issue s2, April 2007, Pages: 17–23, A. Costanzo, K. Peris, M. Talamonti, A. Di Cesare, M. Concetta Fargnoli, E. Botti and S. Chimenti

    Version of Record online : 16 MAR 2007, DOI: 10.1111/j.1365-2133.2007.07765.x

  7. CLinical experience acquired with the efalizumab (Raptiva®) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trial

    British Journal of Dermatology

    Volume 155, Issue 1, July 2006, Pages: 170–181, L. Dubertret, W. Sterry, J.D. Bos, S. Chimenti, S. Shumack, C.G. Larsen, N.H. Shear, K.A. Papp and CLEAR Multinational Study Group

    Version of Record online : 26 MAY 2006, DOI: 10.1111/j.1365-2133.2006.07344.x

  8. Efalizumab

    Dermatologic Therapy

    Volume 20, Issue 4, July 2007, Pages: 265–269, Manju Chacko and Jeffrey M Weinberg

    Version of Record online : 25 OCT 2007, DOI: 10.1111/j.1529-8019.2007.00139.x

  9. Efalizumab in routine use: a clinical experience

    British Journal of Dermatology

    Volume 156, Issue s2, April 2007, Pages: 1–6, N. Selenko-Gebauer, F. Karlhofer and G. Stingl

    Version of Record online : 16 MAR 2007, DOI: 10.1111/j.1365-2133.2007.07762.x

  10. The Greek experience with efalizumab in psoriasis from a University Dermatologic Hospital

    British Journal of Dermatology

    Volume 156, Issue s2, April 2007, Pages: 12–16, C. Antoniou, I. Stefanaki, A. Stratigos, G. Avgerinou, P. Stavropoulos, I. Potouridou, D. Polidorou, A.E. Moustou, M. Kosmadaki and A.D. Katsambas

    Version of Record online : 16 MAR 2007, DOI: 10.1111/j.1365-2133.2007.07764.x

  11. You have free access to this content
    Onset of psoriatic arthritis in patients treated with efalizumab for moderate to severe psoriasis

    Arthritis & Rheumatism

    Volume 58, Issue 6, June 2008, Pages: 1796–1802, Manuelle Viguier, Pascal Richette, François Aubin, Marie Beylot-Barry, Morad Lahfa, Christophe Bedane, Franck Delesalle, Marie-Aleth Richard-Lallemand, Emmanuel Delaporte, Louis Dubertret, Thomas Bardin and Hervé Bachelez

    Version of Record online : 31 MAY 2008, DOI: 10.1002/art.23507

  12. CLinical Experience Acquired with Raptiva® (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from extended treatment in an international, Phase III, placebo-controlled trial

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 4, Issue 11, November 2006, Pages: 947–956, Wolfram Sterry, Georg Stingl, Richard G.B. Langley, Hugh Zacharie, Morad Lahfa, Alberto Giannetti, Carlos Ferrándiz, Rodney Sinclair, Jean-Hilaire Saurat and the CLEAR Multinational Study Group

    Version of Record online : 25 OCT 2006, DOI: 10.1111/j.1610-0387.2006.06111.x

  13. The application of mechanism-based PK/PD modeling in pharmacodynamic-based dose selection of muM17, a surrogate monoclonal antibody for efalizumab

    Journal of Pharmaceutical Sciences

    Volume 95, Issue 6, June 2006, Pages: 1258–1268, Benjamin Wu, Amita Joshi, Song Ren and Chee Ng

    Version of Record online : 24 APR 2006, DOI: 10.1002/jps.20475

  14. You have free access to this content
    A Phase I/II Randomized Open-Label Multicenter Trial of Efalizumab, a Humanized Anti-CD11a, Anti-LFA-1 in Renal Transplantation

    American Journal of Transplantation

    Volume 7, Issue 7, July 2007, Pages: 1770–1777, F. Vincenti, R. Mendez, M. Pescovitz, P. R. Rajagopalan, A. H. Wilkinson, K. Butt, D. Laskow, D. P. Slakey, M. I. Lorber, J. P. Garg and M. Garovoy

    Version of Record online : 9 JUN 2007, DOI: 10.1111/j.1600-6143.2007.01845.x

  15. Efalizumab in the treatment of chronic plaque psoriasis: experiences from the largest psoriasis treatment centre in Denmark

    British Journal of Dermatology

    Volume 156, Issue s2, April 2007, Pages: 7–11, Knud Kragballe

    Version of Record online : 16 MAR 2007, DOI: 10.1111/j.1365-2133.2007.07763.x

  16. You have free access to this content
    European S3-Guidelines on the systemic treatment of psoriasis vulgaris

    Journal of the European Academy of Dermatology and Venereology

    Volume 23, Issue s2, October 2009, Pages: 1–70, D Pathirana, AD Ormerod, P Saiag, C Smith, PI Spuls, A Nast, J Barker, JD Bos, G-R Burmester, S Chimenti, L Dubertret, B Eberlein, R Erdmann, J Ferguson, G Girolomoni, P Gisondi, A Giunta, C Griffiths, H Hönigsmann, M Hussain, R Jobling, S-L Karvonen, L Kemeny, I Kopp, C Leonardi, M Maccarone, A Menter, U Mrowietz, L Naldi, T Nijsten, J-P Ortonne, H-D Orzechowski, T Rantanen, K Reich, N Reytan, H Richards, HB Thio, P Van De Kerkhof and B Rzany

    Version of Record online : 26 AUG 2009, DOI: 10.1111/j.1468-3083.2009.03389.x

    Corrected by:

    Erratum

    Vol. 24, Issue 1, 117–118, Version of Record online: 7 DEC 2009

  17. You have full text access to this OnlineOpen article
    Efalizumab: results of a 3-year continuous dosing study for the long-term control of psoriasis

    British Journal of Dermatology

    Volume 158, Issue 5, May 2008, Pages: 1107–1116, C. Leonardi, A. Menter, T. Hamilton, I. Caro, B. Xing and A.B. Gottlieb

    Version of Record online : 28 MAR 2008, DOI: 10.1111/j.1365-2133.2008.08548.x

  18. Efalizumab in the treatment of psoriasis

    Dermatologic Therapy

    Volume 17, Issue 5, October 2004, Pages: 393–400, Craig L. Leonardi

    Version of Record online : 20 SEP 2004, DOI: 10.1111/j.1396-0296.2004.04042.x

  19. Long-term efalizumab therapy for patients with moderate-to-severe, chronic plaque psoriasis: results from an Australian expanded access program

    International Journal of Dermatology

    Volume 48, Issue 12, December 2009, Pages: 1376–1384, Peter Foley, Michael Freeman, Kurt Gebauer, Dedee Murrell, Stephen Shumack, Christopher Tyson and George Varigos

    Version of Record online : 17 NOV 2009, DOI: 10.1111/j.1365-4632.2009.04217.x

  20. Evidence-based (S3) guidelines for the treatment of psoriasis vulgaris

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 5, Issue s3, July 2007, Pages: 1–119, Alexander Nast, Ina B. Kopp, Matthias Augustin, Kirstin-Benita Banditt, Wolf-Henning Boehncke, Markus Follmann, Markus Friedrich, Matthias Huber, Christina Kahl, Joachim Klaus, Joachim Koza, Inga Kreiselmaier, Johannes Mohr, Ulrich Mrowietz, Hans-Michael Ockenfels, Hans-Dieter Orzechowski, Jörg Prinz, Kristian Reich, Thomas Rosenbach, Stefanie Rosumeck, Martin Schlaeger, Gerhard Schmid-Ott, Michael Sebastian, Volker Streit, Tobias Weberschock and Berthold Rzany

    Version of Record online : 5 JUL 2007, DOI: 10.1111/j.1610-0387.2007.06172.x